MLAB 1211 Urinalysis/Body Fluids
 

Unit 5 Objectives: Other Body Fluids

  1. Discuss the major components of seminal fluid with regard to source, function, normal and abnormal appearance.
  2. List three (3) reasons for semen analysis.
  3. Outline instructions to give to a patient for the correct method for collecting a semen specimen for laboratory analysis.
  4. List two (2) methods for identifying a questionable fluid as semen.
  5. State the significance of finding increased acid phosphatase in a suspicious fluid.
  6. Calculate a sperm count when provided with the number of sperm counted, the dilution factor and the area of the counting chamber used.
  7. List the normal values for: semen volume, viscosity, pH, sperm count, motility and morphology.
  8. Describe HCG, explain its role in pregnancy testing, and identify causes for false negative and false positive results.
  9. Analyze the formation, composition, and physiology of amniotic fluid.
  10. State three (3) reasons for amniotic fluid analysis.
  11. Describe tests performed on amniotic fluid to determine risk of Hemoyltic Disease of the Fetus and Newborn (HDFN) and fetal maturity.
  12. Define amniocentesis and list special precautions needed for this procedure.
  13. Describe the handling and processing procedures for testing amniotic fluid.
  14. Explain the principle of spectrophotometric analysis of amniotic fluid for bilirubin and the interpretation of results as to level of risk to the fetus.
  15. Evaluate the L/S ratio including its significance and normal value in a mature fetus.
  16. Identify the significance of phosphatidylglycerol and the “foam” or “shake” test.
  17. Explain the significance of alpha fetal protein and cytogenetic analysis of amniotic fluid.
  18. Define cystic fibrosis (CF).
  19. Describe the methodology of the sweat chloride test.
  20. Analyze the sweat chloride values seen in patients suspected of having CF.
  21. Describe the physiology and composition of gastric fluid; including the role of gastrin in its production.
  22. List two (2) reasons for gastric fluid analysis.
  23. Explain the special patient preparation that should occur before gastric fluid is analyzed.
  24. Define or describe the Zollinger-Ellison Syndrome, anacidity, hypochlorhydria, and achlorhydria.
  25. Describe the procedure for gastric acidity and state the clinical significance.
  26. Describe gastric fluid drug screening and its clinical significance.
  27. Describe the normal contents of a fecal specimen.
  28. List four (4) reasons for performing fecal analysis.
  29. Identify the special patient preparation that should occur before certain fecal analyses are performed.
  30. State the characteristic appearance of a fecal specimen in upper gastrointestinal (GI) bleeding, lower GI bleeding, bile duct obstruction and steatorrhea.
  31. Briefly describe the procedures used and the clinical significance of: fecal leukocytes, fecal fat and occult blood testing.
  32. State reasons for false positive and false negative results for the Guaiac occult blood test.
  33. Discuss the immunochemical fecal occult blood test (iFOBT) to include basic principle and advantages.
  34. Identify the most common organisms causing bacterial and parasitic infections in the stool specimen
  35. Describe and interpret the microscopic results of Sudan III stained fecal smears from normal patients and patients with steatorrhea.
  36. Given a picture of an example test or its description, evaluate the results of an APT test for fetal hemoglobin.
  37. Identify the expected / normal results and significant cells seen in the following fluids: bronchoalveolar lavage, nasal, cyst, tears, and breast milk.
  38. Define and list at least three (3) symptoms of vaginitis.
  39. Identify at least two (2) sources of error that can occur during the collection and processing of vaginal wet prep specimens.
  40. List three (3) common causes of infectious vaginitis.
  41. Describe "clue cells" and explain the significance of finding them in a vaginal wet prep.
  42. Evaluate the test for estrogenic activity including the appearance of positive and negative results.

Last Update: December 9, 2010
Web Author: Carolyn A. Ragland, MSHP, MT(ASCP)BB
Comments: cragland@austincc.edu
- All Rights Reserved